Cargando…
The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years
We compared very elderly people taking vitamin K antagonists (VKA) and those not taking VKA (noVKA). Individuals were included in the noVKA group if there was no VKA on their reimbursed prescriptions during the study period. We also compared three subgroups, constituted by VKA type (fluindione, warf...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558265/ https://www.ncbi.nlm.nih.gov/pubmed/32937847 http://dx.doi.org/10.3390/ijerph17186685 |
_version_ | 1783594602332160000 |
---|---|
author | Manckoundia, Patrick Rosay, Clémentine Menu, Didier Nuss, Valentine Mihai, Anca-Maria Vovelle, Jérémie Nuémi, Gilles d’Athis, Philippe Putot, Alain Barben, Jérémy |
author_facet | Manckoundia, Patrick Rosay, Clémentine Menu, Didier Nuss, Valentine Mihai, Anca-Maria Vovelle, Jérémie Nuémi, Gilles d’Athis, Philippe Putot, Alain Barben, Jérémy |
author_sort | Manckoundia, Patrick |
collection | PubMed |
description | We compared very elderly people taking vitamin K antagonists (VKA) and those not taking VKA (noVKA). Individuals were included in the noVKA group if there was no VKA on their reimbursed prescriptions during the study period. We also compared three subgroups, constituted by VKA type (fluindione, warfarin, or acenocoumarol). We included individuals aged over 85 years, affiliated to Mutualité Sociale Agricole of Burgundy, who were refunded for prescribed VKA in September 2017. The VKA and noVKA groups were compared in terms of demographic conditions, registered chronic diseases (RCD), number of drugs per prescription and cardiovascular medications. The three VKA subgroups were compared for the same items plus laboratory monitoring, novel and refill VKA prescriptions, and prescriber specialty. Of the 8696 included individuals, 1157 (13.30%) were prescribed VKA. Mean age was 90 years. The noVKA group had fewer women (53.67 vs 66.08%), more RCD (93.43 vs. 71.96%) and more drugs per prescription (6.65 vs. 5.18) than the VKA group (all p < 0.01). Except for direct oral anticoagulants and platelet aggregation inhibitors, the VKA group took significantly more cardiovascular medications. The most commonly prescribed VKA was fluindione (59.46%). Mean age was higher in the warfarin (90.42) than in the acenocoumarol (89.83) or fluindione (89.71) subgroups (p < 0.01). No differences were observed for sex (women were predominant) or RCD. 13% of subjects in this population had a VKA prescription. Fluindione was the most commonly prescribed VKA. |
format | Online Article Text |
id | pubmed-7558265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75582652020-10-29 The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years Manckoundia, Patrick Rosay, Clémentine Menu, Didier Nuss, Valentine Mihai, Anca-Maria Vovelle, Jérémie Nuémi, Gilles d’Athis, Philippe Putot, Alain Barben, Jérémy Int J Environ Res Public Health Article We compared very elderly people taking vitamin K antagonists (VKA) and those not taking VKA (noVKA). Individuals were included in the noVKA group if there was no VKA on their reimbursed prescriptions during the study period. We also compared three subgroups, constituted by VKA type (fluindione, warfarin, or acenocoumarol). We included individuals aged over 85 years, affiliated to Mutualité Sociale Agricole of Burgundy, who were refunded for prescribed VKA in September 2017. The VKA and noVKA groups were compared in terms of demographic conditions, registered chronic diseases (RCD), number of drugs per prescription and cardiovascular medications. The three VKA subgroups were compared for the same items plus laboratory monitoring, novel and refill VKA prescriptions, and prescriber specialty. Of the 8696 included individuals, 1157 (13.30%) were prescribed VKA. Mean age was 90 years. The noVKA group had fewer women (53.67 vs 66.08%), more RCD (93.43 vs. 71.96%) and more drugs per prescription (6.65 vs. 5.18) than the VKA group (all p < 0.01). Except for direct oral anticoagulants and platelet aggregation inhibitors, the VKA group took significantly more cardiovascular medications. The most commonly prescribed VKA was fluindione (59.46%). Mean age was higher in the warfarin (90.42) than in the acenocoumarol (89.83) or fluindione (89.71) subgroups (p < 0.01). No differences were observed for sex (women were predominant) or RCD. 13% of subjects in this population had a VKA prescription. Fluindione was the most commonly prescribed VKA. MDPI 2020-09-14 2020-09 /pmc/articles/PMC7558265/ /pubmed/32937847 http://dx.doi.org/10.3390/ijerph17186685 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Manckoundia, Patrick Rosay, Clémentine Menu, Didier Nuss, Valentine Mihai, Anca-Maria Vovelle, Jérémie Nuémi, Gilles d’Athis, Philippe Putot, Alain Barben, Jérémy The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years |
title | The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years |
title_full | The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years |
title_fullStr | The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years |
title_full_unstemmed | The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years |
title_short | The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years |
title_sort | prescription of vitamin k antagonists in a very old population: a cross-sectional study of 8696 ambulatory subjects aged over 85 years |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558265/ https://www.ncbi.nlm.nih.gov/pubmed/32937847 http://dx.doi.org/10.3390/ijerph17186685 |
work_keys_str_mv | AT manckoundiapatrick theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT rosayclementine theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT menudidier theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT nussvalentine theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT mihaiancamaria theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT vovellejeremie theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT nuemigilles theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT dathisphilippe theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT putotalain theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT barbenjeremy theprescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT manckoundiapatrick prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT rosayclementine prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT menudidier prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT nussvalentine prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT mihaiancamaria prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT vovellejeremie prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT nuemigilles prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT dathisphilippe prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT putotalain prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years AT barbenjeremy prescriptionofvitaminkantagonistsinaveryoldpopulationacrosssectionalstudyof8696ambulatorysubjectsagedover85years |